Ryosuke Shimizu

7PUBLICATIONS
49CO-AUTHORS
Infectious diseasesCardiology (incl. cardiovascular diseases)Cheminformatics and quantitative structure-activity relationshipsMolecular medicineEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 22, 2026
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial.

|Apr 01, 2026
Prospective Study of Treatment with Ensitrelvir for COVID-19 in Patients Undergoing Hemodialysis (PROTECT-HD).

Mineaki Kitamura, Takahiro Takazono, Naoki Hosogaya

|Mar 31, 2026
Effects of Ensitrelvir on the Pharmacokinetics of Combined Oral Contraceptives (Ethinyl Estradiol/Drospirenone) in Healthy Adult Women: A Phase 1 Fixed-Sequence, Multiple-Dose, Drug-Drug Interaction Study.

Ryosuke Shimizu, Risa Yokokawa Shibata, Ryuji Kubota

|Nov 20, 2024
Population Pharmacokinetics of Ensitrelvir in Healthy Participants and Participants with SARS-CoV-2 Infection in the SCORPIO-SR Study.

Toru Ishibashi, Ryosuke Shimizu, Ryuji Kubota

|Oct 07, 2024
Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19.

Daichi Yamaguchi, Masaya M Saito, Ayano Hata

|May 24, 2024
Development of a SARS-CoV-2 viral dynamic model for patients with COVID-19 based on the amount of viral RNA and viral titer.

Daichi Yamaguchi, Ryosuke Shimizu, Ryuji Kubota

Pageof 2

Frequent Collaborators

3 joint publications

Ryuji Kubota

2 joint publications

Daichi Yamaguchi

1 joint publications

Masaya M Saito

1 joint publications

Shogo Miyazawa